Related Experiment Video
Updated: May 24, 2026
10:37
Ferric Chloride-induced Murine Thrombosis Models
Published on: September 5, 2016
Transporters in human platelets: physiologic function and impact for pharmacotherapy
Gabriele Jedlitschky1, Andreas Greinacher, Heyo K Kroemer
1Department of Pharmacology, Center of Drug Absorption and Transport, Ernst-Moritz-Arndt-University, Greifswald, Germany. jedlits@uni-greifswald.de
Blood
|February 17, 2012
Summary
Platelets utilize transporters to manage signaling molecules and drugs, influencing their effects. Understanding these platelet transporters is key for drug development and managing platelet function.
Area of Science:
- Hematology
- Molecular Biology
- Pharmacology
Background:
- Platelets store and release signaling molecules like serotonin and ADP via transporters.
- Transporter activity in platelets dictates intracellular concentrations of molecules and drugs.
- Key transporter families, ATP-binding cassette (ABC) and solute carriers (SLCs), are present in platelets.
Purpose of the Study:
- To review the physiological and pharmacological roles of transporters in platelets.
- To highlight the importance of transporter balance in platelet function and drug response.
Main Methods:
- Literature review of studies identifying and characterizing platelet transporters.
- Analysis of data on ABC transporters (e.g., MRP4) and SLC transporters (e.g., SERT, OATP2B1) in platelets.
Main Results:
- MRP4 (ABCC4) facilitates ADP accumulation and is implicated in lipid mediator release and aspirin resistance.
- The serotonin transporter (SERT, SLC6A4) is a well-characterized SLC transporter in the platelet plasma membrane.
- OATP2B1 (SLCO2B1) is expressed in platelets, transporting statins.
- Platelet transporter expression and localization influence platelet function and drug sensitivity.
Conclusions:
- Platelet transporters play critical roles in regulating platelet signaling and drug metabolism.
- Understanding platelet transporter dynamics is essential for predicting drug efficacy and side effects.
- Further research into platelet transporters can inform therapeutic strategies targeting platelet-related conditions.
More Related Videos
Related Concept Videos
01:20Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
01:07Physiological Pharmacokinetic Models: Incorporating Hepatic Transporter-Mediated Clearance
Drug transporters are critical in drug absorption, distribution, and excretion processes. They should be included in physiological-based pharmacokinetic (PBPK) models, which help predict human drug disposition. However, predicting this is challenging during drug development, especially when liver transport is involved. However, with a realistic representation of body transport processes, an accurate model may be possible.
A recent model describes pravastatin's hepatobiliary excretion, mediated...
A recent model describes pravastatin's hepatobiliary excretion, mediated...
01:27Nonlinear Pharmacokinetics: Role of Transporters
A drug's nonlinear kinetics can be influenced by a diverse range of transporter proteins that serve as crucial players in drug distribution. These transporters, found within cells, can enhance or reduce local drug concentrations by facilitating the influx or efflux of drugs. For instance, the expression of xenobiotic transporters can be influenced by factors such as age and gender, potentially impacting the linearity of drug response.
Polymorphisms occurring in drug transporters can alter...
Polymorphisms occurring in drug transporters can alter...
01:14Hepatic Drug Clearance: Role of Transporters
In the liver and bile canaliculi, influx and efflux transporters modification can influence intrinsic clearance. Transporters play a significant role in moving drugs within liver cells. Elaborate models, such as the Biopharmaceutical Classification System (BCS), are essential to relate transporters to drug disposition. This system categorizes drugs into four classes based on solubility and permeability, providing insights into elimination routes and the effects of transporters following oral...
01:30Anticoagulant Drugs: Low-Molecular-Weight Heparins
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
01:29Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...